English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Cancer types are commonly classified on the basis of the Histopathology. The molecular characterizations have led to the proposal of prognostic biomarkers of many cancer types. Nevertheless most of these biomarkers have been proposed for specific cancer types or even specific sub types. Although more challenging, it is useful to identify biomarkers that can be applied to multiple types of cancer. Here we discuss several such integrative computational and analytical approaches to identify genes that are expressed during multiple types of cancer. This analysis will help us to identify the novel signature biomarker common for multiple types of cancer, so that a novel drug can be proposed which will be responsive towards multiple cancer genes.

IDENTIFICATION OF THE MULTICANCER GENE EXPRESSION BIO-MARKER WITH RESPECT TO DRUG TARGET INTERACTION.